Diagnostics Scorecard
Executive Summary
The diagnostics industry is likely to continue to consolidate, with mid-sized companies particularly vulnerable. But M&A isn't a panacea. Merrill Lynch has graded the progress of top mergers by product integration, cohesive branding, costs savings, and synergies.